| Dr Mark Andrew Clifford, MD | |
|
122 1st Ave, Suite 600, Fairbanks, AK 99701-4803 | |
| (907) 750-4124 | |
| (808) 433-1558 |
| Full Name | Dr Mark Andrew Clifford |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 21 Years |
| Location | 122 1st Ave, Fairbanks, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003834086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 13429 (Hawaii) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 13429 (Hawaii) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanana Chiefs Conference | 9537050109 | 100 |
News Archive
Ontario Nurses' Association (ONA) President Linda Haslam-Stroud, RN is calling for the Ontario government to use limited health-care funding available where it's going to matter most: improving patients' health outcomes by preserving registered nursing positions that are being cut as hospitals struggle to balance budgets.
Pennsylvania Hospital has announced that it has been named an American Society for Metabolic and Bariatric Surgery (ASMBS) Bariatric Surgery Center of Excellence.
A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).
The decision comes amid controversy surrounding the costs of new drugs to treat the blood-borne virus. Meanwhile, two studies find that Medicare could save billions if doctors switched from an expensive eye medication to a similar, much cheaper one and, also, if Part D plans were selected based on the actual drugs patients take.
› Verified 9 days ago
| Entity Name | Tanana Chiefs Conference |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821201278 PECOS PAC ID: 9537050109 Enrollment ID: O20050111000954 |
News Archive
Ontario Nurses' Association (ONA) President Linda Haslam-Stroud, RN is calling for the Ontario government to use limited health-care funding available where it's going to matter most: improving patients' health outcomes by preserving registered nursing positions that are being cut as hospitals struggle to balance budgets.
Pennsylvania Hospital has announced that it has been named an American Society for Metabolic and Bariatric Surgery (ASMBS) Bariatric Surgery Center of Excellence.
A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).
The decision comes amid controversy surrounding the costs of new drugs to treat the blood-borne virus. Meanwhile, two studies find that Medicare could save billions if doctors switched from an expensive eye medication to a similar, much cheaper one and, also, if Part D plans were selected based on the actual drugs patients take.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Andrew Clifford, MD 122 1st Ave, Suite 600, Fairbanks, AK 99701-4803 Ph: (907) 750-4124 | Dr Mark Andrew Clifford, MD 122 1st Ave, Suite 600, Fairbanks, AK 99701-4803 Ph: (907) 750-4124 |
News Archive
Ontario Nurses' Association (ONA) President Linda Haslam-Stroud, RN is calling for the Ontario government to use limited health-care funding available where it's going to matter most: improving patients' health outcomes by preserving registered nursing positions that are being cut as hospitals struggle to balance budgets.
Pennsylvania Hospital has announced that it has been named an American Society for Metabolic and Bariatric Surgery (ASMBS) Bariatric Surgery Center of Excellence.
A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes.
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).
The decision comes amid controversy surrounding the costs of new drugs to treat the blood-borne virus. Meanwhile, two studies find that Medicare could save billions if doctors switched from an expensive eye medication to a similar, much cheaper one and, also, if Part D plans were selected based on the actual drugs patients take.
› Verified 9 days ago
Dr. Patrick D Dean, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1650 Cowles Street, Fairbanks, AK 99701 Phone: 907-458-5415 | |
Janice Onorato, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1867 Airport Way, Ste 205, Fairbanks, AK 99701 Phone: 907-455-7003 Fax: 866-465-7729 | |
Monique Dase Smith, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1717 W Cowles St, Fairbanks, AK 99701 Phone: 907-459-3800 | |
Ronald A Martino, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1919 Lathrop St, Ste 220, Fairbanks, AK 99701 Phone: 907-452-1739 Fax: 907-452-2384 | |
Adam Miguel Estevez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 160 Cowles St, Fairbanks Memorial Hospital, Fairbanks, AK 99701 Phone: 907-458-5525 Fax: 907-458-5514 | |
Dr. Sasha Elizabeth Ericksen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 122 1st Ave Ste 600, Fairbanks, AK 99701 Phone: 907-459-3800 Fax: 907-459-3810 | |
Jereme T. Vaughan, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3101 Lathrop St, Fairbanks, AK 99701 Phone: 907-459-4700 |